Russian-Similar Cancer Drug: Vietnamese Patient Outcomes & Costs
Tumors Significantly Reduced Pembroria vial with pembrolizumab, a cancer treatment drugPembroria, containing the active ingredient pembrolizumab, 100mg/4ml vial, manufactured by Limited Liability “PK-137” in the Russian Federation, received its marketing authorization on October 31st, drawing significant public attention. The Drug Administration of Vietnam (Ministry of Health) also affirmed that this newly licensed Russian cancer drug…
